26.02.2020 • News

Avantium Divests Bioaromatics Portfolio

Avantium Divests Bioaromatics Portfolio (c) Avantium
Avantium Divests Bioaromatics Portfolio (c) Avantium

Dutch renewables specialist Avantium has sold its bioaromatics patent portfolio to The Netherlands Organization for Applied Scientific Research, TNO, for an undisclosed sum.

The sale includes patents and know-how for technologies that produce bio-derived products for polymers and coatings. Avantium said these technologies lie outside its strategic focus and will now be developed further by TNO.

“This bioaromatics patent portfolio fits well into TNO’s development strategy. Avantium will continue to support TNO in this area and can provide proprietary single flow testing equipment to accelerate TNO’s R&D efforts,” said Zanna McFerson, managing director of Avantium Renewable Chemistries.

Last month, Avantium Renewable Polymers signed a letter of intent to build a 5,000 t/y plant for bio-based furandicarboxylic acid (FDCA), a key building block for polyethylene furanoate (PEF). The facility, located at Chemie Park Delfzijl in the Netherlands, is expected to start production in 2023.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read